Patent ID: 6960355

Claim:
A pharmacological composition comprising: (A) at least one biologically-active agent; and (B) at least one carrier compound having the formula 2—HO—Ar—CONR 8 —R 7 —COOH or a salt thereof, wherein Ar is a phenyl or naphthyl substituted with at least one of C 1 -C 5 alkyl, C 2 -C 4 alkenyl, —F, —Cl, —OH, —SO 2 , —COOH or —SO 3 H; R 7 is selected form the group consisting of C 4 to C 20 alkyl, C 4 to C 20 alkenyl, phenyl, naphthyl, (C 1 to C 10 alkyl)phenyl, (C 1 to C 10 alkenyl)phenyl, (C 1 to C 10 alkyl)naphthyl, (C 1 to C 10 alkenyl)naphthyl, phenyl (C 1 to C 10 alkyl), phenyl (C 1 to C 10 alkenyl), naphthyl (C 1 to C 10 alkyl) and naphthyl (C 1 to C 10 alkenyl); R 7 is optionally substituted with C 1 to C 4 alkyl, C 1 to C 4 alkenyl, C 1 to C 4 alkoxy, —OH, —SH and —CO 2 R 9 or any combination thereof; R 7 is optionally interrupted by oxygen, nitrogen, sulfur or any combination thereof; R 8 is selected from the group consisting of hydrogen, C 1 to C 4 alkyl, C 1 to C 4 alkenyl, hydroxy, and C 1 to C 4 alkoxy; and R 8 is optionally substituted with C 1 to C 4 alkyl, C 1 to C 4 alkenyl, C 1 to C 4 alkoxy, —OH, —SH and —CO 2 R 9 or any combination thereof; R 9 is hydrogen, C 1 to C 4 alkyl, or C 1 to C 4 alkenyl; with the proviso that the compounds are not substituted with an amino group in the position alpha to the acid group.